Boule Diagnostics AB (publ) (STO:BOUL)
Sweden
· Delayed Price · Currency is SEK 9.04
+0.26 (2.96%)
Mar 28, 2025, 5:29 PM CET
Boule Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 558.5 | 571.33 | 548.09 | 463.34 | 400.46 | Upgrade
|
| Revenue Growth (YoY) | -2.25% | 4.24% | 18.29% | 15.70% | -19.73% | Upgrade
|
| Cost of Revenue | 303.3 | 321.62 | 320.18 | 264.71 | 223.27 | Upgrade
|
| Gross Profit | 255.2 | 249.71 | 227.91 | 198.64 | 177.19 | Upgrade
|
| Selling, General & Admin | 146.8 | 153.35 | 143.6 | 120.15 | 110.94 | Upgrade
|
| Research & Development | 302.8 | 53.09 | 51.57 | 43.33 | 43.05 | Upgrade
|
| Other Operating Expenses | 6.6 | -0.23 | -0.74 | -0.7 | -0.79 | Upgrade
|
| Operating Expenses | 456.2 | 206.21 | 194.43 | 162.78 | 153.19 | Upgrade
|
| Operating Income | -201 | 43.5 | 33.48 | 35.86 | 24 | Upgrade
|
| Interest Expense | -12.6 | -11.3 | -9.85 | -5.49 | -4.21 | Upgrade
|
| Interest & Investment Income | 1.4 | 1.14 | 1.78 | 1.35 | 0.31 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -40.28 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -3.24 | -4.5 | -2.95 | -0.47 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.1 | 0 | -0 | -0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -212.1 | 30.1 | 20.9 | 28.77 | -20.66 | Upgrade
|
| Merger & Restructuring Charges | -22.9 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.05 | - | 0.08 | Upgrade
|
| Asset Writedown | -33.5 | - | - | - | -40.05 | Upgrade
|
| Other Unusual Items | - | - | - | - | 11.6 | Upgrade
|
| Pretax Income | -268.5 | 30.1 | 20.85 | 28.77 | -49.02 | Upgrade
|
| Income Tax Expense | -45.2 | 5.12 | 8.12 | 5.5 | -1.06 | Upgrade
|
| Net Income | -223.3 | 24.98 | 12.73 | 23.27 | -47.97 | Upgrade
|
| Net Income to Common | -223.3 | 24.98 | 12.73 | 23.27 | -47.97 | Upgrade
|
| Net Income Growth | - | 96.24% | -45.31% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 39 | 39 | 28 | 27 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 28 | 27 | 19 | Upgrade
|
| Shares Change (YoY) | 0.00% | 36.37% | 4.65% | 40.14% | - | Upgrade
|
| EPS (Basic) | -5.75 | 0.64 | 0.46 | 0.87 | -2.47 | Upgrade
|
| EPS (Diluted) | -5.75 | 0.64 | 0.45 | 0.86 | -2.47 | Upgrade
|
| EPS Growth | - | 42.22% | -47.67% | - | - | Upgrade
|
| Free Cash Flow | 37.7 | 44.51 | -17.79 | 40.14 | 70.65 | Upgrade
|
| Free Cash Flow Per Share | 0.97 | 1.15 | -0.63 | 1.48 | 3.64 | Upgrade
|
| Dividend Per Share | - | - | - | 0.550 | 0.550 | Upgrade
|
| Gross Margin | 45.69% | 43.71% | 41.58% | 42.87% | 44.25% | Upgrade
|
| Operating Margin | -35.99% | 7.61% | 6.11% | 7.74% | 5.99% | Upgrade
|
| Profit Margin | -39.98% | 4.37% | 2.32% | 5.02% | -11.98% | Upgrade
|
| Free Cash Flow Margin | 6.75% | 7.79% | -3.25% | 8.66% | 17.64% | Upgrade
|
| EBITDA | -182.7 | 60.64 | 54.14 | 51.17 | 41.48 | Upgrade
|
| EBITDA Margin | -32.71% | 10.61% | 9.88% | 11.04% | 10.36% | Upgrade
|
| D&A For EBITDA | 18.3 | 17.14 | 20.66 | 15.31 | 17.48 | Upgrade
|
| EBIT | -201 | 43.5 | 33.48 | 35.86 | 24 | Upgrade
|
| EBIT Margin | -35.99% | 7.61% | 6.11% | 7.74% | 5.99% | Upgrade
|
| Effective Tax Rate | - | 17.02% | 38.95% | 19.11% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.